1. Home
  2. MED vs TVGN Comparison

MED vs TVGN Comparison

Compare MED & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$12.77

Market Cap

122.8M

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$6.20

Market Cap

21.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MED
TVGN
Founded
1980
2020
Country
United States
United States
Employees
N/A
18
Industry
Packaged Foods
Blank Checks
Sector
Consumer Staples
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
122.8M
21.3M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
MED
TVGN
Price
$12.77
$6.20
Analyst Decision
Hold
Hold
Analyst Count
1
1
Target Price
$12.00
N/A
AVG Volume (30 Days)
207.7K
12.4K
Earning Date
05-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$934,842,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.22
$0.14
52 Week High
$14.67
$12.03

Technical Indicators

Market Signals
Indicator
MED
TVGN
Relative Strength Index (RSI) 62.11 53.24
Support Level $9.90 $6.33
Resistance Level $12.21 $7.42
Average True Range (ATR) 0.56 0.67
MACD 0.33 0.35
Stochastic Oscillator 67.24 75.16

Price Performance

Historical Comparison
MED
TVGN

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: